Product Information
EVEROLIMUS 1 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $6.7564 per EA under NDC 00054060421. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
1 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054060421
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA206133On Market Since
11/18/2021
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 1 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7564 per EA |
|---|---|
| All-time high | $16.6894 (May 15, 2024) |
| All-time low | $6.7564 (Jun 17, 2026) |
| 52-week high | $14.5977 |
| 52-week low | $6.7564 |
| Median price | $14.1184 |
| Average price | $12.8914 |
| Largest weekly change | -31.0% (Jul 17, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 1 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $6.7564 per EA (NDC 00054060421), effective Jun 24, 2026.
How has the price of EVEROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 1 MG TABLET has declined 59.5%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 1 MG TABLET?
Since Apr 17, 2024, the NADAC for EVEROLIMUS 1 MG TABLET has ranged from a low of $6.7564 (Jun 17, 2026) to a high of $16.6894 (May 15, 2024), with a median of $14.1184 per EA.
Are there cheaper alternatives to EVEROLIMUS 1 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 1 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 1 MG TABLET?
EVEROLIMUS 1 MG TABLET (NDC 00054060421) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification